High-dose sequential followed by autologous hematopoietic stem cell transplantation for Hodgkin's disease (hd): a Brazilian experience

被引：0
|
作者：
Duarte, B. [1 ]
Valente, I. [1 ]
Vigorito, A. [1 ]
Aranha, F. [1 ]
Oliveira, G. [1 ]
Miranda, E. [1 ]
Lorand-Metze, I. [1 ]
Pagnano, K. [1 ]
De Souza, C. [1 ]
机构：
[1] Univ Estadual Campinas, Campinas, SP, Brazil
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [31] High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease
    Burt, RK
    Traynor, A
    Oyama, Y
    Craig, R
    BLOOD, 2003, 101 (05) : 2064 - 2066
  • [32] High-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) for patients with rhabdomyosarcomas (RMS)
    Peinemann, F.
    Hildebrandt, M.
    Kulig, M.
    Herrmann-Frank, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma
    Cakar, Merih K.
    Tekgunduz, Emre
    Dal, Mehmet S.
    Merdin, Alparslan
    Basci, Semih
    Iskender, Dicle
    Ugur, Bilge
    Bekdemir, Filiz
    Yildiz, Jale
    Ulu, Bahar U.
    Bakirtas, Mehmet
    Yigenoglu, Tugce N.
    Batgi, Hikmetullah
    Kaya, Ali H.
    Altuntas, Fevzi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 273 - 278
  • [34] High dose therapy followed by autologous stem cell transplantation (ASCT) for patients with primary refractory Hodgkin's disease (HD): Evaluation of prognostic factors.
    Fung, HC
    Nademananee, A
    Palmer, JM
    Molina, A
    Kashyap, A
    Spielberger, R
    Hilger, J
    O'Donnell, M
    Snyder, D
    Stein, A
    Parker, P
    Bhatia, R
    Krishnan, A
    Rodriguez, R
    Vora, N
    Niland, J
    Forman, SJ
    BLOOD, 1999, 94 (10) : 175A - 175A
  • [35] Efficacy of a BCNU-based high dose conditioning regimen (CBV1) followed by autologous hematopoietic stem cell transplantation (HSCT) in relapsed or refractory Hodgkin's disease (HD).
    Qazilbash, MH
    Lynch, JP
    Beall, CL
    Auber, M
    Weisenborn, R
    Bunner, P
    Hobbs, G
    Ericson, SG
    BLOOD, 2000, 96 (11) : 374B - 374B
  • [36] The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Phillips, GL
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 53 - 56
  • [37] High dose therapy and autologous hematopoietic stem cell transplantation (auto HSCT) with an intensive VCB conditioning regimen for relapsed and refractory Hodgkin's disease (HD).
    Alam, AR
    Younis, T
    Hahn, T
    Bernstein, Z
    Chanan-Khan, AA
    Czuczman, M
    Silva, J
    Becker, J
    McCarthy, P
    BLOOD, 2002, 100 (11) : 863A - 864A
  • [38] Role of high-dose chemotherapy with autologous haematopoetic stem cell transplantation for relapsed or refractory Hodgkin's disease.
    Kumar, Ambuj
    Djulbegovic, Benjamin
    Soares, Heloisa P.
    BLOOD, 2006, 108 (11) : 453B - 453B
  • [39] Favourable results of high-dose chemotherapy and autologous stem cell transplantation for patients with poor prognosis of Hodgkin's disease
    Kral, Z
    Pytlik, R
    Raida, L
    Koza, V
    Slaby, J
    Dusek, L
    Wagnerova, B
    Vackova, B
    Faber, E
    Kozak, T
    Muzik, J
    Vasova, I
    Trnkova, M
    Papajik, T
    Markova, J
    Navratil, M
    Indrak, K
    Mayer, J
    Trneny, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S75 - S75
  • [40] Role of high dose chemotherapy and autologous hematopoietic stem cell transplantation in Hodgkin lymphoma
    不详
    ONCOLOGY IN CLINICAL PRACTICE, 2008, 4 : A1 - A22
12345